Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Three-month results from Progenta uterine fibroid study

March 8, 2005

Alliance and Leo amend Oxygent exclusivity agreement

March 8, 2005

Torcetrapib improves the lipid profile of patients with dyslipidemia

March 8, 2005

Novel SARM effective in preclinical tests as hormonal male contraception / News in Context

March 8, 2005

Insulin mimetic is an alternative therapeutic agent for diabetes

March 8, 2005

Icatibant reported at the ASCPT meeting

March 7, 2005

Japan Tobacco scientists announce the synthesis of new HLGPa inhibitors for diabetes

March 7, 2005

Merck scientists present new dipeptidyl peptidase IV inhibitors for type 2 diabetes

March 7, 2005

Thyrogen receives new European approval

March 7, 2005

Crestor labeling revision approved by FDA

March 7, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...